Literature DB >> 8501186

Homologous intra-uterine insemination has no advantage over timed natural intercourse when used in combination with ovulation induction for the treatment of unexplained infertility.

K Zikopoulos1, C P West, P W Thong, E M Kacser, J Morrison, F C Wu.   

Abstract

The objective was to evaluate the role of homologous intrauterine insemination compared with timed natural intercourse, both combined with ovulation induction, in the management of unexplained infertility. A total of 48 couples presenting at a large teaching hospital infertility clinic with unexplained infertility of at least 3 years duration comprised the main study group, and 36 couples with identical entry criteria but under the care of another clinician made up a parallel control group. A randomized design of treatment cycles with within-group and between-group controls was used. Couples in the main study group were treated with either homologous intra-uterine insemination or timed natural intercourse in gonadotrophin-releasing hormone analogue down-regulated cycles, in which ovulation was induced with human menopausal gonadotrophin and human chorionic gonadotrophin. Alternate cycles were monitored to enable optimum timing of natural intercourse provided within-group controls. Couples in the control group underwent timed homologous intravaginal artificial insemination. Cycle fecundity and pregnancy outcome in treated and control groups were monitored. Cycle fecundity of 0.11 in 85 ovulation-induced cycles was significantly higher than 0.02 in 62 within-group and 0.01 in 103 between-group control cycles. There was no difference in conception rates between homologous intra-uterine insemination and timed natural intercourse cycles with ovulation induction. Of the 11 established pregnancies in the ovulation induced group, nine delivered healthy babies (five singleton, three twin, one triplet) and two were ectopic. Results confirmed the value of active management for couples with long-standing unexplained infertility but failed to demonstrate any advantage of homologous intra-uterine insemination over ovulation induction alone.

Entities:  

Mesh:

Year:  1993        PMID: 8501186     DOI: 10.1093/oxfordjournals.humrep.a138096

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  6 in total

1.  Antagonist use in intrauterine insemination (IUI) cycles.

Authors:  Nur Dokuzeylül
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-12-01

Review 2.  Pharmacological interventions for the induction of ovulation.

Authors:  J A Collins; E G Hughes
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

3.  Tubal catheterization for intrafallopian insemination and transvaginal gamete (GIFT) or zygote intrafallopian transfer (ZIFT): our experience in a total of 1128 treatment cycles.

Authors:  J Tzafettas; A Loufopoulos; A Stephanatos; A Mukherjee
Journal:  J Assist Reprod Genet       Date:  1994-07       Impact factor: 3.412

4.  Interventions for unexplained infertility: a systematic review and network meta-analysis.

Authors:  Rui Wang; Nora A Danhof; Raissa I Tjon-Kon-Fat; Marinus Jc Eijkemans; Patrick Mm Bossuyt; Monique H Mochtar; Fulco van der Veen; Siladitya Bhattacharya; Ben Willem J Mol; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05

5.  Intra-uterine insemination for unexplained subfertility.

Authors:  Reuben Olugbenga Ayeleke; Joyce Danielle Asseler; Ben J Cohlen; Susanne M Veltman-Verhulst
Journal:  Cochrane Database Syst Rev       Date:  2020-03-03

6.  Comparing clomiphen citrate plus HMG with clomiphen citrate plus rFSH in IUI cycles in couples with unexplained or male factor infertility: A prospective randomized study.

Authors:  Azam Azargoon; Marjan Bahrami; Jafar Alavy Toussy
Journal:  Iran J Reprod Med       Date:  2013-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.